Investors | SynAct Pharma

Investors

Press releases

October 20, 2020Notice of extraordinary shareholders’ meeting in SynAct Pharma AB
October 20, 2020Shareholders of SynAct Pharma proposes Uli Hacksell as new board member
October 19, 2020SynAct Pharma terminates agreement for liquidity providing
October 12, 2020English version of PR published 20201012 at 07.33AM SynAct Pharma completes part 1 of clinical phase II study with AP1189 in Rheumatoid Arthritis

All press releases

News

April 2, 2020BIOSTOCK: Synact Pharma on expansion into Covid-19 (also available in Swedish)
April 1, 2020Synact Pharma in spotlightanalysen (in Swedish)
October 28, 2019Redeye: Adding an indication
July 5, 2019Kliniska bevis för behandlingseffekter av melanokortiner vid reumatoid artrit

Calendar

October 26, 2020 - October 28, 2020Bio Europe 2020
November 16, 2020Sedermeradagen Stockholm

Subscribe to our press releases